Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium.

peer reviewed ; In Belgium, nursing home (NH) staff (NHS) and residents were prioritised for the initial COVID-19 vaccination and successive booster doses. The vaccination campaign for the first booster started in September 2021 in Belgian NH. Our first study about vaccine hesitancy towards the COVID-19 vaccine in Belgian NHS already showed a degree of fear for the primary vaccination course (T1). This new study aims to evaluate vaccine hesitancy to get the first booster (T2) in a population of fully vaccinated (with two doses) NHS. A random stratified sample of NHS who received the primary va... Mehr ...

Verfasser: Di Gregorio, Marina
Van Ngoc, Pauline
Delogne, Simon
Meyers, Eline
Deschepper, Ellen
Dardenne, Nadia
Duysburgh, Els
De Rop, Liselore
De Burghgraeve, Tine
Coen, Anja
De Clercq, Nele
De Sutter, An
Verbakel, Jan Y
Cools, Piet
Heytens, Stefan
Buret, Laetitia
Scholtes, Béatrice
Dokumenttyp: journal article
Erscheinungsdatum: 2024
Verlag/Hrsg.: Elsevier BV
Schlagwörter: Belgium / Booster dose / COVID-19 / COVID-19 vaccination / COVID-19 vaccine booster dose / Nursing home / SARS-CoV-2 / Staff / Vaccine hesitancy / Infectious Diseases / Public Health / Environmental and Occupational Health / General Veterinary / General Immunology and Microbiology / Molecular Medicine / Human health sciences / health care sciences & services / Sciences de la santé humaine / Santé publique / services médicaux & soins de santé
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26985377
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://orbi.uliege.be/handle/2268/313425

peer reviewed ; In Belgium, nursing home (NH) staff (NHS) and residents were prioritised for the initial COVID-19 vaccination and successive booster doses. The vaccination campaign for the first booster started in September 2021 in Belgian NH. Our first study about vaccine hesitancy towards the COVID-19 vaccine in Belgian NHS already showed a degree of fear for the primary vaccination course (T1). This new study aims to evaluate vaccine hesitancy to get the first booster (T2) in a population of fully vaccinated (with two doses) NHS. A random stratified sample of NHS who received the primary vaccination course (N = 954) completed an online questionnaire on COVID-19 booster hesitancy (between 25/11/2021 and 22/01/2022). NHS who hesitated or refused the booster were asked for the main reason for their hesitation/refusal. Overall, 21.0 % of our population hesitated before, were still hesitating or refused the booster, NHS that were not hesitant at T1 being 5.7 times less likely to hesitate to get the first booster dose (Adjusted OR 0.179, 95 % CI: 0.120, 0.267). Although there was a slight reduction (23.5 % to 20.1 %) in the proportion of NHS who hesitated/refused vaccination at T1 compared to T2 (p = 0.034), the fear of unknown effects was the principal reason for hesitation/refusal, already mentioned in our first study. NHS were not reassured concerning their initial fears. Given the likelihood that booster vaccinations will be necessary over the coming years, a communication strategy specific to NHS should be implemented. ; CHARMING